New data for baricitinib in rheumatoid arthritis presented at EULAR
Lilly and Incyte have announced new data for baricitinib in rheumatoid arthritis (RA) at the Annual European Congress of Rheumatology (EULAR 2016).
List view / Grid view
News
Efficacy and safety of Biogen’s anti-TNF biosimilars presented at EULAR
9 June 2016 | By Victoria White, Digital Content Producer
Data demonstrating long-term comparable efficacy, safety and immunogenicity of Benepali (etanercept) and Flixabi (infliximab) have been presented at EULAR...
Promising Phase I/II results for GenSight’s GS010 in LHON
9 June 2016 | By Victoria White, Digital Content Producer
The Phase I/II study was designed to demonstrate the safety and tolerability of GS010 in 15 patients with Leber’s Hereditary Optic Neuropathy...
New Managed Access programme for isavuconazole
9 June 2016 | By Victoria White, Digital Content Producer
The programme will enable patients with serious fungal infections in EU states where the treatment is not yet commercially available to access isavuconazole...
AMG 334 significantly reduces monthly migraine days in study
9 June 2016 | By Victoria White, Digital Content Producer
Novartis has announced positive first results from a Phase II investigating the efficacy and safety of AMG 334 (erenumab) in chronic migraine prevention...
AGI acquires rights to AstraZeneca’s anaesthetics portfolio outside US
9 June 2016 | By Victoria White, Digital Content Producer
AGI is to acquire the rights, outside the US, to AstraZeneca’s portfolio of anaesthetics for an upfront consideration of $520 million...
Bristol-Myers Squibb shares significant new findings in rheumatoid arthritis research
8 June 2016 | By Mandy Parrett, Editorial Assistant
Global biopharma company, Bristol-Myers Squibb, will present new data and offer insights into the field of rheumatoid arthritis at the Annual European Congress of Rheumatology (EULAR 2016) this week.
Greater response with GSK’s Benlysta vs placebo in SLE study
8 June 2016 | By Victoria White, Digital Content Producer
Patients with SLE experienced a significantly greater response to treatment with Benlysta administered via subcutaneous injection compared to placebo...
Sirukumab meets both co-primary endpoints in rheumatoid arthritis study
8 June 2016 | By Victoria White, Digital Content Producer
The SIRROUND-D study met both co-primary endpoints in evaluating treatment with sirukumab in adult patients with active rheumatoid arthritis...
Novartis plans head-to-head studies of Cosentyx versus Humira
8 June 2016 | By Victoria White, Digital Content Producer
Long-term analyses suggest Cosentyx may lead to higher responses than Humira in improving signs and symptoms of ankylosing spondylitis and psoriatic arthritis...
EC approves Avastin plus Tarceva in NSCLC
8 June 2016 | By Victoria White, Digital Content Producer
The combination is approved for the first-line treatment of adult patients with non-squamous NSCLC with EGFR-activating mutations...
Positive top-line results for tofacitinib citrate in active psoriatic arthritis
8 June 2016 | By Victoria White, Digital Content Producer
The OPAL Beyond study met its primary efficacy endpoints demonstrating a statistically significant improvement with tofacitinib 5 mg BID and 10 mg BID...
Meningococcal vaccines market to approach $1.8b by 2025, says GlobalData
7 June 2016 | By Victoria White, Digital Content Producer
The meningococcal vaccines market is expected to grow from around $1.1 billion in 2015 to $1.8 billion by 2025, according to GlobalData...
Two new types of childhood leukaemia discovered
7 June 2016 | By Victoria White, Digital Content Producer
Using next-generation sequencing technology, researchers were able to study the genome of cancer cells, which is how they discovered the new cancer types...
BMS and MD Anderson in lung cancer research collaboration
7 June 2016 | By Victoria White, Digital Content Producer
BMS and MD Anderson are to collaborate to evaluate innovative strategies for the use of Opdivo and Yervoy to treat lung cancer patients...
